Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.
Jan 2011 - Blood; 117(2):1528-0020 [PMID:21030562]
[Rosenblatt J] [Vasir B] [Uhl L] [Blotta S] [Macnamara C] [Somaiya P] [Wu Z] [Joyce R] [Levine JD] [Dombagoda D] [Yuan YE] [Francoeur K] [Fitzgerald D] [Richardson P] [Weller E] [Anderson K] [Kufe D] [Munshi N] [Avigan D]

Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28.
Feb 2010 - :1537-4513 [PMID:20145548]
[Rosenblatt J] [Wu Z] [Vasir B] [Zarwan C] [Stone R] [Mills H] [Friedman T] [Konstantinopoulos PA] [Spentzos D] [Ghebremichael M] [Stevenson K] [Neuberg D] [Levine JD] [Joyce R] [Tzachanis D] [Boussiotis V] [Kufe D] [Avigan D]